Growth HormonePrices may be stale · 8d ago

CJC-1295 No-DAC

CJC-1295 without DAC, also called modified GRF 1-29, is a short acting GHRH analogue that stimulates pulsatile growth hormone release. Removing the drug affinity complex shortens its action to around 30 minutes, so it is often paired in research settings with a ghrelin mimetic such as ipamorelin to extend the effect.

Lowest cost / mg: $2.90/mg; at Licensed Peptides
Suppliers listed: 49
In stock: 74 of 79; listings
COA reports: 56

Jump to

Overview Supplier Listings Benefits Evidence Interactions FAQ

Supplier listings

Compare CJC-1295 (No DAC) prices.

Form

Show prices as

Size

77 listings · CJC-1295 (No DAC)

Nura PeptideFeatured partner placement, shown above the price ranking
In stock5mgseen 2w ago
$23.20
$29.00$4.64/mg-20%
PEPLOOKUP
Licensed PeptidesLowest $/mg
In stock10 mg · 2 vialsseen 3w ago
$55.09
$57.99$2.75/mg-5%
peplookup
Pure Peptides UK
In stock2mgseen 2w ago
$17.25
$8.63/mg
Peppy&Me
In stock5mgseen 7w ago
$18.00
$20.00$3.60/mg-10%
peplookup
Eon Peptides
In stock5mgseen 2w ago
$20.25
$22.50$4.05/mg-10%
PEPLOOKUP
Alpha Peptides
In stock10mgseen 7w ago
$26.85
$29.83$2.69/mg-10%
peplookup
Biologix Labs
In stock5mgseen 5w ago
$26.99
$29.99$5.40/mg-10%
PEPLOOKUP
BioPeptide Technologies
In stock5mgseen 7w ago
$25.50
$30.00$5.10/mg-15%
peplookup
Pepvida Labs
In stock5mgseen 7w ago
$24.00
$30.00$4.80/mg-20%
PEPLOOKUP
Ares Research Lab
In stock2mgseen 7w ago
$29.74
$34.99$14.87/mg-15%
PRODUCTS
GenPeptide
In stock5mgseen 7w ago
$31.50
$35.00$6.30/mg-10%
adamdan
Elite Edge Biotech
In stock5mgseen 7w ago
$31.50
$35.00$6.30/mg-10%
10ADAMDAN668
Ameano Peptides
In stock5mgseen 7w ago
$34.20
$38.00$6.84/mg-10%
PEPLOOKUP
Amino Club
In stock10mgseen 7w ago
$31.19
$38.99$3.12/mg-20%
PRODUCTS
Pure Peptides
In stock5mgseen 4w ago
$39.00
$7.80/mg
Vertex Labs
In stock5mgseen 7w ago
$35.10
$39.00$7.02/mg-10%
products
IDUN Peptides
In stock10mgseen 7w ago
$35.99
$39.99$3.60/mg-10%
PEPLOOKUP
HLX Labs
In stock5mgseen 7w ago
$35.99
$39.99$7.20/mg-10%
products
Kalyx Labs
In stock5mgseen 7w ago
$29.99
$39.99$6.00/mg-25%
adamdan
Prime Peptide Solutions
In stock5mgseen 7w ago
$35.99
$39.99$7.20/mg-10%
PEPLOOKUP

Trusted Peps
In stock10mgseen 7w ago
$36.00
$40.00$3.60/mg-10%
products
PuraTek Peptides
In stock10mgseen 5w ago
$40.46
$44.95$4.05/mg-10%
PEPLOOKUP
Peptides Canada
In stock5mgseen 7w ago
$38.24
$44.99$7.65/mg-15%
PEPLOOKUP
Peptide Giants
In stock5mgseen 7w ago
$40.50
$45.00$8.10/mg-10%
adamdan
Bioinfinity
In stock5mgseen 7w ago
$40.50
$45.00$8.10/mg-10%
adamdaFAKR
Prpeps
In stock10mgseen 7w ago
$40.50
$45.00$4.05/mg-10%
peplookup
Peptide Titans
In stock5mgseen 7w ago
$44.99
$49.99$9.00/mg-10%
products
Rejuven8 Peptides
In stock5mgseen 7w ago
$42.50
$50.00$8.50/mg-15%
adam15
Blank Peptides
In stock5mgseen 7w ago
$45.00
$50.00$9.00/mg-10%
peplookup
Ascension Peptides
In stock5mgseen 7w ago
$25.00
$50.00$5.00/mg-50%
products
NextGen Peps
In stock5mgseen 7w ago
$48.60
$54.00$9.72/mg-10%
PEPLOOKUP
Void Research
In stock10mgseen 7w ago
$53.99
$59.99$5.40/mg-10%
PEPLOOKUP
Palmetto Peptides
In stock5mgseen 7w ago
$54.00
$60.00$10.80/mg-10%
PRODUCTS
Blue Ridge Peptides
In stock10mgseen 7w ago
$54.00
$60.00$5.40/mg-10%
products
Pivot Labs
In stock2mgseen 7w ago
$51.00
$60.00$25.50/mg-15%
adamdan
Sparta Labs
In stock5mgseen 7w ago
$55.25
$65.00$11.05/mg-15%
PEPLOOKUP
Aero Peptides
In stock10mgseen 7w ago
$69.99
$7.00/mg
Axon Chems
In stock10mgseen 6w ago
$63.00
$70.00$6.30/mg-10%
Dlj7pbr
MsAmino
In stock10mgseen 7w ago
$59.99
$74.99$6.00/mg-20%
W9QVLNLY
Apex Peptides Lab
In stock5mgseen 7w ago
$66.30
$78.00$13.26/mg-15%
peplookup
Disguised Alpha
In stock10mgseen 4w ago
$71.99
$79.99$7.20/mg-10%
PEPLOOKUP
Vantage Aminos
In stock5mgseen 7w ago
$72.00
$80.00$14.40/mg-10%
peplookup
AminoVault
In stock10mgseen 7w ago
$70.81
$83.30$7.08/mg-15%
PEPLOOKUP
Amino Science
In stock10mgseen 7w ago
$69.59
$86.99$6.96/mg-20%
PRODUCTS
American Peptides
In stock10mgseen 7w ago
$99.00
$110.00$9.90/mg-10%
peplookup
Peptide Labs Inc
In stock2 mg · 10 vialsseen 7w ago
$161.99
$179.99$8.10/mg-10%
PEPLOOKUP
True Peptides
Out of stock5mgseen 7w ago
$31.50
$35.00$6.30/mg-10%
PEPLOOKUP
RIVN Research
Out of stock5mgseen 7w ago
$33.99
$39.99$6.80/mg-15%
adamdan668815

Overview

What is CJC-1295 (No DAC)?

GH Support
Recovery
Body Composition
Sleep Quality

What the research reports

Benefits of CJC-1295 (No DAC)

Outcomes described across the published CJC-1295 (No DAC) literature and ongoing study. Read each as research context, not a promised result.

01
Pulsatile GH stimulation work
Acts on the pituitary GHRH receptor to raise growth hormone while preserving the body's own pulse pattern rather than flattening it. Reported in research settings.
02
Pairs with ghrelin mimetics
The short acting form is usually combined with ipamorelin, where the two pathways together produce a larger pulse than either alone. Reported in research settings.
03
Shorter drug exposure window
Without the drug affinity complex the action lasts roughly 30 minutes, so IGF-1 does not stay elevated between doses. Described in the research record.
04
Dose flexibility in protocols
The brief action means research use typically involves multiple smaller pulses across a day rather than one sustained level, mirroring the body's own episodic GH release pattern.
05
Established GHRH mechanism
The parent molecule with DAC raised growth hormone and IGF-1 dose dependently in healthy adults in a published phase 1 programme. Reported in research settings.

Clinical evidence

Clinical evidence and study base

The published record, labeled by strength so you can see what is settled and what is still emerging.

CJC-1295 phase 1 human study

A 2006 trial of the long-acting DAC form of CJC-1295 reported sustained, dose-dependent increases in growth hormone and IGF-1 in healthy adults, well tolerated at doses up to 180 mcg/kg. This trial tested the DAC version; it does not describe the no-DAC form on this page, which clears the body in roughly 30 minutes rather than producing a sustained effect.

Source

No trials of the no DAC form

No published clinical trial has tested the shorter acting no DAC version on its own. Human data comes from the DAC form and general GHRH research. Reported in the cited paper.

Source

Secretagogue IGF-1 cohort

A 2017 cohort in hypogonadal men reported raised serum IGF-1 after growth hormone secretagogue therapy, the closest human outcome data for this class. Reported in the cited paper.

Source

Interactions

How it pairs with other peptides

Ipamorelin: Synergistic for GH release. GHRH analogue plus ghrelin mimetic amplifies the pulse through two pathways.
GHRP-2 peptide: Also synergistic, though GHRP-2 adds more appetite, cortisol and prolactin effect than ipamorelin does.
BPC-157 peptide: No known negative interaction. Tissue repair and growth hormone release act on separate systems.
MK-677 oral: Stacking secretagogues compounds IGF-1 elevation and the insulin resistance risk associated with GH-axis activation; this is a known pharmacological interaction, not dosing guidance.

Questions

Frequently asked questions.

What is CJC-1295 (No DAC)?

CJC-1295 without DAC, also known as Modified GRF (1-29), is a synthetic peptide fragment of growth hormone-releasing hormone (GHRH). Removing the drug affinity complex (DAC) shortens its activity to roughly 30 minutes, unlike the long-acting DAC version.

What are the research benefits of CJC-1295 (No DAC)?

Research has explored its ability to stimulate pulsatile growth hormone release from the pituitary while preserving the body's natural pulse pattern, and its use alongside ghrelin-mimetic peptides to produce a combined GH response, though direct clinical trial data on the no-DAC form specifically remains limited.

How does CJC-1295 (No DAC) work?

It binds the GHRH receptor on the pituitary gland, prompting a short, defined pulse of growth hormone release. Because it lacks the DAC's drug-binding extension, it clears the body quickly rather than producing a sustained elevation.

Is CJC-1295 (No DAC) for research use only?

Yes. CJC-1295 (No DAC) is sold and discussed here strictly for laboratory and research purposes. PepLookup does not provide dosing, administration, or protocol guidance for any compound; consult the primary literature cited in the Evidence section above.

What should I look for before buying CJC-1295 (No DAC)?

Check for third-party Certificate of Analysis (COA) results confirming identity and purity, confirm the supplier specifies "No DAC" rather than the long-acting DAC form, and compare pricing and documentation across the suppliers listed on this page before choosing a source.

CJC-1295 No-DAC

Lowest cost / mg

$2.90/mg

at Licensed Peptides

Suppliers listed

In stock

74 of 79

listings

COA reports

What is CJC-1295 (No DAC)?

GH Support

Recovery

Body Composition

Sleep Quality

Benefits of CJC-1295 (No DAC)

Outcomes described across the published CJC-1295 (No DAC) literature and ongoing study. Read each as research context, not a promised result.

Pulsatile GH stimulation work

Acts on the pituitary GHRH receptor to raise growth hormone while preserving the body's own pulse pattern rather than flattening it. Reported in research settings.

Pairs with ghrelin mimetics

The short acting form is usually combined with ipamorelin, where the two pathways together produce a larger pulse than either alone. Reported in research settings.

Shorter drug exposure window

Without the drug affinity complex the action lasts roughly 30 minutes, so IGF-1 does not stay elevated between doses. Described in the research record.

Dose flexibility in protocols

The brief action means research use typically involves multiple smaller pulses across a day rather than one sustained level, mirroring the body's own episodic GH release pattern.

Established GHRH mechanism

The parent molecule with DAC raised growth hormone and IGF-1 dose dependently in healthy adults in a published phase 1 programme. Reported in research settings.

Clinical evidence and study base

The published record, labeled by strength so you can see what is settled and what is still emerging.

CJC-1295 phase 1 human study

Source

No trials of the no DAC form

No published clinical trial has tested the shorter acting no DAC version on its own. Human data comes from the DAC form and general GHRH research. Reported in the cited paper.

Source

Secretagogue IGF-1 cohort

A 2017 cohort in hypogonadal men reported raised serum IGF-1 after growth hormone secretagogue therapy, the closest human outcome data for this class. Reported in the cited paper.

Source

How it pairs with other peptides

Ipamorelin

Synergistic for GH release. GHRH analogue plus ghrelin mimetic amplifies the pulse through two pathways.

GHRP-2 peptide

Also synergistic, though GHRP-2 adds more appetite, cortisol and prolactin effect than ipamorelin does.

BPC-157 peptide

No known negative interaction. Tissue repair and growth hormone release act on separate systems.

MK-677 oral

Stacking secretagogues compounds IGF-1 elevation and the insulin resistance risk associated with GH-axis activation; this is a known pharmacological interaction, not dosing guidance.